A retrospective study assessing the predictive factors for completion of all six cycles of radium-223 (Ra-223) treatment in patients with metastatic castration-resistant Prostate cancer
Latest Information Update: 17 Feb 2022
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 17 Feb 2022 New trial record